Annotation Detail

Information
Associated Genes
TWNK
Associated Variants
BRCA2 p.Tyr1655Ter (p.Y1655*) ( ENST00000544455.6, ENST00000380152.8, ENST00000713678.1, ENST00000530893.7, ENST00000700202.2, ENST00000713680.1 )
BRCA2 p.Tyr1655Ter (p.Y1655*) ( ENST00000530893.7, ENST00000544455.6, ENST00000380152.8, ENST00000713678.1, ENST00000713680.1, ENST00000700202.2 )
BRCA2 p.Tyr1655Ter (p.Y1655*) ( ENST00000380152.8, ENST00000530893.7, ENST00000544455.6, ENST00000700202.2, ENST00000713678.1, ENST00000713680.1 )
BRCA2 p.Tyr1655Ter (p.Y1655*) ( ENST00000380152.8, ENST00000530893.7, ENST00000544455.6, ENST00000700202.2, ENST00000713678.1, ENST00000713680.1 )
Associated Disease
Malignant neoplasm of ovary
Source Database
DisGeNET
Description
Three ovarian cancer cell lines (PEO1, PEO4, and PEO6) were derived from a BRCA2 mutation [5193C>G (Y1655X)] carrier with ovarian carcinoma with acquired cisplatin resistance and a secondary BRCA2 mutation [5193C>T (Y1655Y)] that canceled the inherited mutation.
Pubmed
19654294
Original source reporting the Gene Disease association
BeFree
DisGENET score for the Gene Disease association
0.00190009310456212
Year of publication
2009
Drugs